Update on the Treatment of Ataxia: Medication and Emerging Therapies

17Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

While rehabilitation therapies always help patients with ataxia, there are currently no FDA-approved treatments for ataxia. Medications are available to treat symptoms that may complicate an ataxic illness, e.g., tremor, myoclonus, dystonia, and rigidity, which are discussed elsewhere in this volume. Spasticity, pain, fatigue, depression, sleep disturbances, cognitive decline, and bowel and bladder dysfunction, if they occur, all have multiple available drugs and therapies for symptomatic use. There is also an extensive literature on off-label uses of various medications to improve imbalance. The pipeline of emerging therapies for symptomatic and possible disease-modifying management of ataxia gives hope that we will soon see the first of many FDA-approved drugs for ataxic illnesses.

Cite

CITATION STYLE

APA

Perlman, S. L. (2020, October 1). Update on the Treatment of Ataxia: Medication and Emerging Therapies. Neurotherapeutics. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s13311-020-00941-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free